Export 10 results:
Author Keyword Title [ Type(Desc)] Year
Filters: Author is Rissman, Robert A  [Clear All Filters]
Journal Article
J. A. Soria, Huisa, B. N., Edland, S. D., Litvan, I., Peavy, G. M., Salmon, D. P., Hansen, L. A., Galasko, D. R., Brewer, J. B., González, H. M., and Rissman, R. A., Clinical-Neuropathological Correlations of Alzheimer's Disease and Related Dementias in Latino Volunteers., J Alzheimers Dis, vol. 66, no. 4, pp. 1539-1548, 2018.
S. Sokolow, Li, X., Chen, L., Taylor, K. D., Rotter, J. I., Rissman, R. A., Aisen, P. S., and Apostolova, L. G., Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment., J Alzheimers Dis, vol. 56, no. 1, pp. 229-237, 2017.
A. J. Hanson, Bayer, J. L., Baker, L. D., Cholerton, B., VanFossen, B., Trittschuh, E., Rissman, R. A., Donohue, M. C., Moghadam, S. H., Plymate, S. R., and Craft, S., Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipoprotein E ɛ4 Carriers and Adults with Mild Cognitive Impairment., J Alzheimers Dis, vol. 48, no. 1, pp. 205-18, 2015.
C. N. Winston, Goetzl, E. J., Baker, L. D., Vitiello, M. V., and Rissman, R. A., Growth Hormone-Releasing Hormone Modulation of Neuronal Exosome Biomarkers in Mild Cognitive Impairment., J Alzheimers Dis, vol. 66, no. 3, pp. 971-981, 2018.
O. Prikhodko, Rynearson, K. D., Sekhon, T., Mante, M. M., Nguyen, P. D., Rissman, R. A., Tanzi, R. E., and Wagner, S. L., The GSM BPN-15606 as a Potential Candidate for Preventative Therapy in Alzheimer's Disease., J Alzheimers Dis, vol. 73, no. 4, pp. 1541-1554, 2020.
A. Arner, Rockenstein, E., Mante, M., Florio, J., Masliah, D., Salehi, B., Adame, A., Overk, C., Masliah, E., and Rissman, R. A., Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau., J Alzheimers Dis, vol. 61, no. 3, pp. 1201-1219, 2018.
C. N. Winston, Aulston, B., Rockenstein, E. M., Adame, A., Prikhodko, O., Dave, K. N., Mishra, P., Rissman, R. A., and Yuan, S. H., Neuronal Exosome-Derived Human Tau is Toxic to Recipient Mouse Neurons in vivo., J Alzheimers Dis, vol. 67, no. 2, pp. 541-553, 2019.
M. S. Rafii, Lukic, A. S., Andrews, R. D., Brewer, J., Rissman, R. A., Strother, S. C., Wernick, M. N., Pennington, C., Mobley, W. C., Ness, S., and Matthews, D. C., PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)., J Alzheimers Dis, vol. 60, no. 2, pp. 439-450, 2017.
S. E. O'Bryant, Zhang, F., Johnson, L. A., Hall, J., Edwards, M., Grammas, P., Oh, E., Lyketsos, C. G., and Rissman, R. A., A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's Disease., J Alzheimers Dis, vol. 66, no. 1, pp. 97-104, 2018.
S. E. O'Bryant, Zhang, F., Petersen, M., Hall, J. R., Johnson, L. A., Yaffe, K., Braskie, M., Vig, R., Toga, A. W., and Rissman, R. A., Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study., J Alzheimers Dis, vol. 86, no. 3, pp. 1243-1254, 2022.